COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID-19?

Zeinab AryanianKamran BalighiBaseerat SajadNafiseh EsmaeliMaryam DaneshpazhoohNasim Mazloumi TootoonchiFereshteh BeigmohammadiZeinab Mohseni AfsharParvaneh Hatami

Published in: Journal of cosmetic dermatology (2023)

Rituximab appears to be safe with no increased risk of severe form of COVID-19 in patients with pemphigus vulgaris.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
diffuse large b cell lymphoma
ejection fraction
newly diagnosed
chronic kidney disease
respiratory syndrome coronavirus
prognostic factors
patient reported outcomes